| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,217.60
|
|
Change (%)
|
8.40 (0.69%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,167.30
-
1,222.15
|
|
52-Week Range (RS)
|
1,025.90
-
1,377.95
|
|
Beta (1 Year)
|
0.76
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, bse carbonex |
| News |
|
Corporate Details |
| Dr Reddy's Lab gets EIR from USFDA for Srikakulam facility |
| Dr. Reddy’s Labs acquires 'Progynova' portfolio from UK's Mercury Pharma Group |
| Nifty drops below 25,650 mark; auto shares snap 2-day gains |
| Dr Reddy’s Lab Q3 PAT drops 14% YoY to Rs 1,210 cr |
| Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter |
| Dr Reddy’s Swiss subsidiary gets USFDA CRL for biosimilar AVT03 |
| Dr Reddys Laboratories to announce Quarterly Result |
| Dr Reddys Laboratories allots 9,165 equity shares under ESOS |
| Dr Reddy’s Lab arm inks pact with Immutep SAS for novel cancer immunotherapy |
| Dr Reddys Laboratories Ltd up for five straight sessions |
|
|
|
| Incoporation Year : 1984 |
| Chairman : K Satish Reddy |
| Ownership Group : Dr. Reddy's |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Dr Reddys Laboratories Ltd
8-2-337 Road No 3,
Banjara Hills,
Hyderabad,
Telangana-500034 |
Phone:91-40-49002900
Fax:91-40-49002999 |
| E-Mail : shares@drreddys.com; mail@drreddys.com |
| URL : http://www.drreddys.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
27-Mar-2026 |
1281.95 |
-5.02 |
| 1Month |
02-Mar-2026 |
1294.65 |
-5.95 |
| 3Month |
02-Jan-2026 |
1255.45 |
-3.01 |
| 6Month |
03-Oct-2025 |
1248.10 |
-2.44 |
| 1Year |
02-Apr-2025 |
1149.75 |
5.90 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Parag Parikh Flexi Cap Fund |
1.32 |
1771.22 |
| SBI Nifty 50 ETF |
0.68 |
1456.94 |
| ICICI Pru Value Fund |
2.07 |
1251.60 |
| Nippon India Large Cap Fund |
1.34 |
689.13 |
| Nippon India Pharma Fund |
5.81 |
482.33 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,694.65 |
-1.96 |
1,850.95 |
1,547.25 |
406,603.30 |
| Lupin Ltd |
2,276.80 |
0.14 |
2,376.00 |
1,774.00 |
104,090.54 |
| Cipla Ltd |
1,193.40 |
-0.21 |
1,672.20 |
1,165.55 |
96,400.78 |
| Zydus Lifesciences Ltd |
864.25 |
0.09 |
1,059.00 |
797.05 |
86,963.77 |
| Mankind Pharma Ltd |
1,997.45 |
-0.18 |
2,726.75 |
1,909.90 |
82,460.39 |
|
|
|
|